“Breaking News: Takeda-Backed Ascentage Pharma Plans to Raise $126 Million in US IPO by 2025”
Breaking News: Ascentage Pharma Seeks IPO in the U.S. Ascentage Pharma made headlines on Thursday when it announced its plans to raise $126.4 million in an initial public offering in the United States. This move marks the first major Chinese company to seek a listing in the U.S. this year, showcasing the growing trend of…